KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 147 filers reported holding KARUNA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,735,540 | -86.6% | 10,264 | -82.9% | 0.00% | -75.0% |
| Q2 2023 | $12,997,338 | +91.3% | 59,937 | +73.3% | 0.00% | +33.3% |
| Q4 2022 | $6,795,167 | -36.8% | 34,581 | -27.7% | 0.00% | -40.0% |
| Q3 2022 | $10,757,000 | +1941.2% | 47,824 | +1048.2% | 0.01% | – |
| Q2 2022 | $527,000 | -94.6% | 4,165 | -94.6% | 0.00% | -100.0% |
| Q1 2022 | $9,767,000 | +72.7% | 77,035 | +78.5% | 0.00% | +50.0% |
| Q4 2021 | $5,654,000 | +1185.0% | 43,158 | +1098.8% | 0.00% | – |
| Q3 2021 | $440,000 | -17.9% | 3,600 | -23.4% | 0.00% | – |
| Q2 2021 | $536,000 | -49.3% | 4,700 | -46.6% | 0.00% | – |
| Q1 2021 | $1,058,000 | -35.1% | 8,800 | -45.2% | 0.00% | – |
| Q4 2020 | $1,630,000 | +33.0% | 16,048 | +1.2% | 0.00% | -100.0% |
| Q3 2020 | $1,226,000 | -81.2% | 15,863 | -72.9% | 0.00% | -75.0% |
| Q2 2020 | $6,517,000 | +710.6% | 58,467 | +447.8% | 0.00% | +300.0% |
| Q4 2019 | $804,000 | – | 10,673 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
| Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
| Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
| First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
| Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
| DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
| Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
| GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
| MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
| Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |